Hackensack University Medical Center
Hackensack, New Jersey, 07601, United States
NCT Number: NCT02213055
* To evaluate the efficacy of LiceMD for the treatment of head lice in a pediatric population. * To evaluate the safety of LiceMD in a pediatric population.
Looking for future studies?
Notify Me3 year–12 year
All sexes
Interventional
Phase 2
Hackensack, New Jersey, 07601, United States
Head lice, or Pediculus humanus capitis, cause an estimated 6 to 12 million infestations per year in the U.S., most commonly affecting children 3 to 11 years of age. Despite common perceptions, head lice crawl, and cannot hop or fly. For this reason, transmission occurs most often by human head-to-head contact, and much less commonly by the sharing of personal items such as hats, coats, combs, or towels. Because head lice feed on human blood, they cannot live on pets and are only viable 1-2 days on surfaces other than the human head.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Parents/guardians of infested children will provide consent for their child's participation. Infested children whose parents agree to use the investigational product will be enrolled on the experimental arm of the study using the LiceMD product as treatment. Participants will be examined for lice count and scalp irritation the day after the first application, and one and two weeks after the first application.
Other names: Generic Name: Dimethicone
The most common treatments are pesticide-based, over-the-counter remedies of permethrin (1%), or pyrethrin-based products.After baseline scalp exam for lice count and preexisting signs of irritation, parents who agree to the comparison arm may purchase any other head lice treatment of their choice. All treatments are to be done at home by a parent or guardian. All participants will be examined for lice count and scalp irritation the day after the first application, and one and two weeks after the first application. Participants may also be examined by parents or the school nurse at any time if signs of irritation or re-infestation occur. If the child is still found to be infested during any examination, the school nurse will instruct the parent/guardian to retreat.
Other names: permethrin (5%), malathion (0.5%), lindane (1%)
Time frame: Day after first treatment and Day 14 of study
A determination of head lice effectiveness, measured by number of subjects free of live lice and by number of subjects free of viable eggs, was calculated using two week post-treatment data as the primary study outcome. Measurements were calculated at Day 1 (day after first treatment) and Day 14.
At diagnosis, 55 subjects had viable eggs with three subjects meeting enrollment criteria for three or more live lice.
Hackensack Meridian Health
Other
Safety and Efficacy of a 100% Dimethicone Pediculocide in School-Age Children
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05565820
Ectoparasitic Infestations, Head Lice
Miami, Florida, United States
View Trial DetailsNCT02974088
Ectoparasitic Infestations, Head Lice
Cambridge, United Kingdom
View Trial DetailsNCT00528021
Ectoparasitic Infestations, Head Lice
Florida City, Florida, United States
View Trial DetailsNCT06333054
Head Lice
Erfurt, Germany
View Trial Details